Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tharimmune, Inc. | Director | Options (right to buy) | 27.4K | Aug 9, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
THAR | Tharimmune, Inc. | Aug 9, 2024 | 1 | $0 | 4 | Aug 12, 2024 | Director |
THAR | Tharimmune, Inc. | Nov 7, 2022 | 1 | $0 | 4 | Nov 9, 2023 | Director |
HILS | Hillstream BioPharma Inc. | Mar 21, 2022 | 1 | $0 | 4 | Mar 23, 2022 | Director |
HILS | Hillstream BioPharma Inc. | Jan 11, 2022 | 0 | $0 | 3 | Jan 11, 2022 | Director |